GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Black Bird Biotech BBBT · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Price performance

Chart by TradingView, with its own licensed prices

Black Bird Biotech — daily BBBT Delayed
Market value
$98,405
Last close × shares
Volume
2m
Shares, 30 Oct 2026

About Black Bird Biotech

Its shares trade under the ticker BBBT. It has been listed since 10 December 2007. In the fiscal year to 31 December 2023, it reported revenue of $36,323 and a net loss of $836,135.

Black Bird Biotech, Inc. engages in the manufacture and sale of cannabidiol products through its subsidiary, Black Bird Potentials, Inc. Its products include MiteXstream, Grizzly Creek Naturals, and Black Bird American Hemp. The company is headquartered in Argyle, Texas. The company went IPO on 2007-12-10. The firm also manufactures and sells, under its Grizzly Creek Naturals brand name, cannabidiol (CBD) products, including CBD Oils, gummies and pet treats, as well as CBD-infused personal care products. Big Sky American Dist., LLC (Big Sky American) distributes its Grizzly Creek Naturals products, as well as an array of other consumer retail products, in Western Montana. The firm's subsidiaries include Black Bird Potentials Inc. (BB Potentials), Big Sky American Dist., LLC (Big Sky American) and Black Bird Hemp Manager, LLC.

Figures and description from our data supplier, not checked against the company's own report.

More about Black Bird Biotech →

Latest on Black Bird Biotech

Our reporting

We have not reported on Black Bird Biotech yet.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Black Bird Biotech's ticker?

Black Bird Biotech trades as BBBT on its US listing, under ISIN US09183V1017.

What was Black Bird Biotech's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.